Make Better Underwriting Decisions Amid the COVID-19 Pandemic
This webinar was featured live February 3 and 4, 2021.
Please register to view the recording.
The COVID-19 pandemic is adding unprecedented complexity to underwriting, and insurers are under pressure to adapt. Join us for a review of the latest COVID-19-related developments on vaccines, medications, severity indicators, and interpretation tools so you can better assess individual risk and make informed underwriting decisions.
Topics covered
-
- COVID-19 treatments
- Risk factors for severe cases and post-acute COVID-19 syndrome
- Vaccination strategies and implications
- An Irix enhancement that automatically groups electronic health data into specific conditions
- Examples that illustrate the differences in mild and severe COVID-19 cases
Who should attend
This session is intended for medical directors, underwriters, and other clinical and insurance professionals who want to heighten their understanding and interpretation of COVID-19 risks.
Presenter
Scott Coller, PharmD
Product Manager, Medical Data, Milliman IntelliScript
Dan Fleischman, PharmD, BCPS
Manager, Clinical Services, Milliman IntelliScript
